A Study of Obinutuzumab(GA101) in Combination With High-Dose Methylprednisolone(HDMP) in Chronic Lymphocytic Leukemia(CLL) Patients (GA101 & HDMP)
Clinical trial NCT02229422 · UNKNOWN
Trial details
- NCT number
- NCT02229422
- Sponsor
- University of California, San Diego
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2025-10-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.